Cargando…

Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity

Neuronal insulin resistance is a significant feature of Alzheimer’s disease (AD). Accumulated evidence has revealed the possible neuroprotective mechanisms of antidiabetic drugs in AD. Liraglutide, a glucagon-like peptide-1 (GLP-1) analog and an antidiabetic agent, has a benefit in improving a perip...

Descripción completa

Detalles Bibliográficos
Autores principales: Jantrapirom, Salinee, Nimlamool, Wutigri, Chattipakorn, Nipon, Chattipakorn, Siriporn, Temviriyanukul, Piya, Inthachat, Woorawee, Govitrapong, Piyarat, Potikanond, Saranyapin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084306/
https://www.ncbi.nlm.nih.gov/pubmed/32138327
http://dx.doi.org/10.3390/ijms21051725
_version_ 1783508691360677888
author Jantrapirom, Salinee
Nimlamool, Wutigri
Chattipakorn, Nipon
Chattipakorn, Siriporn
Temviriyanukul, Piya
Inthachat, Woorawee
Govitrapong, Piyarat
Potikanond, Saranyapin
author_facet Jantrapirom, Salinee
Nimlamool, Wutigri
Chattipakorn, Nipon
Chattipakorn, Siriporn
Temviriyanukul, Piya
Inthachat, Woorawee
Govitrapong, Piyarat
Potikanond, Saranyapin
author_sort Jantrapirom, Salinee
collection PubMed
description Neuronal insulin resistance is a significant feature of Alzheimer’s disease (AD). Accumulated evidence has revealed the possible neuroprotective mechanisms of antidiabetic drugs in AD. Liraglutide, a glucagon-like peptide-1 (GLP-1) analog and an antidiabetic agent, has a benefit in improving a peripheral insulin resistance. However, the neuronal effect of liraglutide on the model of neuronal insulin resistance with Alzheimer’s formation has not been thoroughly investigated. The present study discovered that liraglutide alleviated neuronal insulin resistance and reduced beta-amyloid formation and tau hyperphosphorylation in a human neuroblostoma cell line, SH-SY5Y. Liraglutide could effectively reverse deleterious effects of insulin overstimulation. In particular, the drug reversed the phosphorylation status of insulin receptors and its major downstream signaling molecules including insulin receptor substrate 1 (IRS-1), protein kinase B (AKT), and glycogen synthase kinase 3 beta (GSK-3β). Moreover, liraglutide reduced the activity of beta secretase 1 (BACE-1) enzyme, which then decreased the formation of beta-amyloid in insulin-resistant cells. This indicated that liraglutide can reverse the defect of phosphorylation status of insulin signal transduction but also inhibit the formation of pathogenic Alzheimer’s proteins like Aβ in neuronal cells. We herein provided the possibility that the liraglutide-based therapy may be able to reduce such deleterious effects caused by insulin resistance. In view of the beneficial effects of liraglutide administration, these findings suggest that the use of liraglutide may be a promising therapy for AD with insulin-resistant condition.
format Online
Article
Text
id pubmed-7084306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70843062020-03-24 Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity Jantrapirom, Salinee Nimlamool, Wutigri Chattipakorn, Nipon Chattipakorn, Siriporn Temviriyanukul, Piya Inthachat, Woorawee Govitrapong, Piyarat Potikanond, Saranyapin Int J Mol Sci Article Neuronal insulin resistance is a significant feature of Alzheimer’s disease (AD). Accumulated evidence has revealed the possible neuroprotective mechanisms of antidiabetic drugs in AD. Liraglutide, a glucagon-like peptide-1 (GLP-1) analog and an antidiabetic agent, has a benefit in improving a peripheral insulin resistance. However, the neuronal effect of liraglutide on the model of neuronal insulin resistance with Alzheimer’s formation has not been thoroughly investigated. The present study discovered that liraglutide alleviated neuronal insulin resistance and reduced beta-amyloid formation and tau hyperphosphorylation in a human neuroblostoma cell line, SH-SY5Y. Liraglutide could effectively reverse deleterious effects of insulin overstimulation. In particular, the drug reversed the phosphorylation status of insulin receptors and its major downstream signaling molecules including insulin receptor substrate 1 (IRS-1), protein kinase B (AKT), and glycogen synthase kinase 3 beta (GSK-3β). Moreover, liraglutide reduced the activity of beta secretase 1 (BACE-1) enzyme, which then decreased the formation of beta-amyloid in insulin-resistant cells. This indicated that liraglutide can reverse the defect of phosphorylation status of insulin signal transduction but also inhibit the formation of pathogenic Alzheimer’s proteins like Aβ in neuronal cells. We herein provided the possibility that the liraglutide-based therapy may be able to reduce such deleterious effects caused by insulin resistance. In view of the beneficial effects of liraglutide administration, these findings suggest that the use of liraglutide may be a promising therapy for AD with insulin-resistant condition. MDPI 2020-03-03 /pmc/articles/PMC7084306/ /pubmed/32138327 http://dx.doi.org/10.3390/ijms21051725 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jantrapirom, Salinee
Nimlamool, Wutigri
Chattipakorn, Nipon
Chattipakorn, Siriporn
Temviriyanukul, Piya
Inthachat, Woorawee
Govitrapong, Piyarat
Potikanond, Saranyapin
Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity
title Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity
title_full Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity
title_fullStr Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity
title_full_unstemmed Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity
title_short Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity
title_sort liraglutide suppresses tau hyperphosphorylation, amyloid beta accumulation through regulating neuronal insulin signaling and bace-1 activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084306/
https://www.ncbi.nlm.nih.gov/pubmed/32138327
http://dx.doi.org/10.3390/ijms21051725
work_keys_str_mv AT jantrapiromsalinee liraglutidesuppressestauhyperphosphorylationamyloidbetaaccumulationthroughregulatingneuronalinsulinsignalingandbace1activity
AT nimlamoolwutigri liraglutidesuppressestauhyperphosphorylationamyloidbetaaccumulationthroughregulatingneuronalinsulinsignalingandbace1activity
AT chattipakornnipon liraglutidesuppressestauhyperphosphorylationamyloidbetaaccumulationthroughregulatingneuronalinsulinsignalingandbace1activity
AT chattipakornsiriporn liraglutidesuppressestauhyperphosphorylationamyloidbetaaccumulationthroughregulatingneuronalinsulinsignalingandbace1activity
AT temviriyanukulpiya liraglutidesuppressestauhyperphosphorylationamyloidbetaaccumulationthroughregulatingneuronalinsulinsignalingandbace1activity
AT inthachatwoorawee liraglutidesuppressestauhyperphosphorylationamyloidbetaaccumulationthroughregulatingneuronalinsulinsignalingandbace1activity
AT govitrapongpiyarat liraglutidesuppressestauhyperphosphorylationamyloidbetaaccumulationthroughregulatingneuronalinsulinsignalingandbace1activity
AT potikanondsaranyapin liraglutidesuppressestauhyperphosphorylationamyloidbetaaccumulationthroughregulatingneuronalinsulinsignalingandbace1activity